STOCK TITAN

Caleres (CAL) director Bruce Thorn receives 12,196 restricted shares as grant

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

THORN BRUCE K reported acquisition or exercise transactions in this Form 4 filing.

Caleres Inc. director Bruce K. Thorn received an equity award of 12,196 shares of Common Stock, valued at $13.12 per share. This is a grant of restricted stock as part of director compensation, not an open-market purchase. Following the grant, Thorn directly holds 36,647 shares. Vesting of the restricted stock is contingent on his continued service as a director through the next annual meeting of shareholders.

Positive

  • None.

Negative

  • None.
Insider THORN BRUCE K
Role null
Type Security Shares Price Value
Grant/Award Common Stock 12,196 $13.12 $160K
Holdings After Transaction: Common Stock — 36,647 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock granted 12,196 shares Common Stock grant to director on transaction date
Grant value per share $13.12 per share Reported transaction price for the restricted stock award
Shares owned after grant 36,647 shares Bruce K. Thorn direct holdings following the transaction
restricted stock financial
"Vesting of restricted stock is contingent on the Director's continued service"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
annual meeting of shareholders regulatory
"continued service as a director through the next annual meeting of shareholders"
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
equity compensation financial
"This is a grant of restricted stock as part of director compensation"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
THORN BRUCE K

(Last)(First)(Middle)
8300 MARYLAND AVENUE

(Street)
ST. LOUIS MISSOURI 63105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CALERES INC [ CAL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/08/2026A12,196(1)A$13.1236,647D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Vesting of restricted stock is contingent on the Director's continued service as a director through the next annual meeting of shareholders.
Becky Helvey, Attny In Fact for Bruce K. Thorn06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Caleres (CAL) director Bruce K. Thorn report in this Form 4?

Bruce K. Thorn reported receiving a grant of 12,196 shares of Caleres Common Stock. The award is equity compensation, not a market purchase, and increases his direct holdings to 36,647 shares after the transaction, according to the Form 4 disclosure.

Is the Bruce K. Thorn share transaction in Caleres (CAL) a stock purchase?

No, the transaction is a grant or award of 12,196 Caleres shares, not an open-market purchase. It reflects equity-based director compensation at an indicated value of $13.12 per share, as described in the Form 4 transaction details.

How many Caleres (CAL) shares does Bruce K. Thorn own after this grant?

After receiving the 12,196-share restricted stock grant, Bruce K. Thorn directly holds 36,647 Caleres Common Stock shares. This total reflects his ownership immediately following the reported Form 4 transaction on the stated transaction date.

What are the vesting conditions for Bruce K. Thorn’s Caleres (CAL) restricted stock?

The restricted stock vests only if Bruce K. Thorn continues serving as a director through the next annual meeting of shareholders. This service-based vesting condition aligns director compensation with ongoing board service, as stated in the Form 4 footnote.

What was the reported value per share of Bruce K. Thorn’s Caleres (CAL) stock grant?

The Form 4 lists a transaction price of $13.12 per Caleres share for the 12,196-share grant. This figure reflects the grant’s per-share value for reporting purposes, rather than a price paid in an open-market trade.